An intranasally delivered Toll-like receptor 7 agonist elicits robust systemic and mucosal responses to Norwalk virus-like particles.
about
Intranasal vaccination with murabutide enhances humoral and mucosal immune responses to a virus-like particle vaccineVaccine against norovirus.Norovirus Narita 104 virus-like particles expressed in Nicotiana benthamiana induce serum and mucosal immune responsesIntranasal delivery of a bivalent norovirus vaccine formulated in an in situ gelling dry powder.TLR7 and 9 agonists are highly effective mucosal adjuvants for norovirus virus-like particle vaccinesHepatitis C VLPs delivered to dendritic cells by a TLR2 targeting lipopeptide results in enhanced antibody and cell-mediated responsesIntranasal delivery of Norwalk virus-like particles formulated in an in situ gelling, dry powder vaccine.Bioprocessing of plant-derived virus-like particles of Norwalk virus capsid protein under current Good Manufacture Practice regulations.Learning from the messengers: innate sensing of viruses and cytokine regulation of immunity - clues for treatments and vaccines.Intravaginal immunisation using a novel antigen-releasing ring device elicits robust vaccine antigen-specific systemic and mucosal humoral immune responses.Developments in virus-like particle-based vaccines for infectious diseases and cancer.The use of Toll-like receptor 7/8 agonists as vaccine adjuvants.Progress towards the prevention and treatment of norovirus infections.Intranasal formulations: promising strategy to deliver vaccines.Adjuvants for foot-and-mouth disease virus vaccines: recent progress.Nasal and pulmonary vaccine delivery using particulate carriers.Current prospects and future challenges for nasal vaccine delivery.Prospects and Challenges in the Development of a Norovirus Vaccine.Overcoming barriers in the mucosal delivery of virus-like particle-based vaccines.
P2860
Q28728786-BBCD2165-AD1C-4055-AD36-DA878D0FF310Q33578075-7057DA19-A3D2-4B43-BDF1-C9550F93A37AQ33681834-AFFCEB09-CEAF-4548-9DE9-B87AE903B0EEQ33703664-D1CD4291-AC14-438F-81F4-05DA7446334EQ34290717-4CC68E23-B42C-4116-84AB-86A6D5F4DC05Q34455275-35CE38C3-9EDF-4EB5-BD38-8411AD998157Q35112676-AACEDC9A-E00F-4496-A50C-7AA42B63FBE9Q35754185-54734A48-2967-40CD-8A5C-A6E210BE06D3Q36807121-29542410-179E-417C-8D66-7A9E3CE85959Q37677269-06B4A722-805D-4538-9AD0-D68FDDB0EFC4Q37951525-AA997F38-C803-497A-93A1-A384834C59EEQ38124064-0D720B32-91EE-46AC-A276-6D406F96AF49Q38160537-7F47E88C-4DDE-4A3E-9278-1209D938984AQ38223050-CBCEBEF7-49E0-4224-8E2E-32E1FDDD31F7Q38252451-8B11EEBA-2F6F-47E9-B96C-0FAC5C381407Q38465267-304C0CC4-CC20-49A3-A2D2-02BFD7865D94Q38784950-41469C2F-7612-4B45-A169-ACF9BD1E61E8Q40102851-1151A0FB-3535-44A1-BB53-9DD4AA781FB0Q44939276-D1EC3642-ADAB-486A-A060-E0B1ADF127BA
P2860
An intranasally delivered Toll-like receptor 7 agonist elicits robust systemic and mucosal responses to Norwalk virus-like particles.
description
2010 nî lūn-bûn
@nan
2010 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
An intranasally delivered Toll ...... Norwalk virus-like particles.
@ast
An intranasally delivered Toll ...... Norwalk virus-like particles.
@en
An intranasally delivered Toll ...... Norwalk virus-like particles.
@nl
type
label
An intranasally delivered Toll ...... Norwalk virus-like particles.
@ast
An intranasally delivered Toll ...... Norwalk virus-like particles.
@en
An intranasally delivered Toll ...... Norwalk virus-like particles.
@nl
prefLabel
An intranasally delivered Toll ...... Norwalk virus-like particles.
@ast
An intranasally delivered Toll ...... Norwalk virus-like particles.
@en
An intranasally delivered Toll ...... Norwalk virus-like particles.
@nl
P2093
P2860
P356
P1476
An intranasally delivered Toll ...... Norwalk virus-like particles.
@en
P2093
Brooke E Hjelm
Charles J Arntzen
Lissette S Velasquez
P2860
P304
P356
10.1128/CVI.00230-10
P577
2010-10-20T00:00:00Z